A decade ago when we published the first edition of the Nanotechnology Opportunity Report(http://www.researchmoz.us/the-graphene-opportunity-report-report.html) , there were predictions of untold riches for early investors, the replacement of all manufacturing as we know it, and the mythical trillion-dollar market. Cientifica went against the grain by predicting that it would be hard for anyone to make money from nanomaterials, and that the real value would be in the applications. This has been borne out by the failure of even large global companies such as Mitsubishi Chemical and Bayer to make much headway with fullerenes and carbon nanotubes, and the failure of countless smaller nanomaterials producers.
On the other hand companies making use of nanomaterials, Germany’s Magforce Technologies and the US based BIND Therapeutics have shown what can be achieved when nanomaterials are applied to large addressable markets, in this case drug delivery.
Is Graphene The New Nanotech?
A similar amount of hype currently surrounds graphene, with wild predictions of applications ranging from microelectronics to water treatment. The Graphene Opportunity Report examines these claims and taking the rational approach for which Cientifica is known, considers how valid these are and evaluates the chances of success. We also look in detail at the graphene producers. Graphene comes in a wide range of forms, each with its own particular set of addressable applications. No one producer covers all applications and many are destined to be niche players. As with nanomaterials, many companies currently producing graphene are destined to burn brightly and then be unceremoniously snuffed out when scale up or access to applications fails to materialise.
For More Information@ http://www.researchmoz.us/the-graphene-opportunity-report-report.html-
See more at: http://www.marketandresearch.org/technology-market/graphene-opportunity-report/